Search clinical trials for: Bortezomib (drug)
Total 256691 results
-
National Cancer Institute (NCI)Millennium Pharmaceuticals, Inc.Withdrawn
-
Boston Medical CenterTerminatedAL AmyloidosisUnited States
-
M.D. Anderson Cancer CenterMillennium Pharmaceuticals, Inc.Active, not recruitingSolid Tumor | Urethral CancerUnited States
-
M.D. Anderson Cancer CenterMillennium Pharmaceuticals, Inc.CompletedLymphoma | Hodgkin LymphomaUnited States
-
Cancer Trials IrelandSanofi; Dana-Farber Cancer InstituteRecruitingMultiple MyelomaDenmark, Ireland
-
Janssen Research & Development, LLCCompleted
-
Massachusetts General HospitalCompletedMultiple MyelomaUnited States
-
University of ArkansasActive, not recruitingMyelomaUnited States
-
Incyte CorporationTerminatedMetastatic Cancer | Solid Tumors | Advanced MalignanciesUnited States
-
UNC Lineberger Comprehensive Cancer CenterNot yet recruitingMultiple Myeloma | Newly Diagnosed Multiple Myeloma | Autologous Stem Cell TransplantationUnited States
-
Jin Lu, MDRecruiting
-
GlaxoSmithKlineRecruitingMultiple MyelomaAustralia, Germany, Italy, Spain, United States, Korea, Republic of, Canada, France, Poland, United Kingdom
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Beth Israel Deaconess Medical Center; Brigham... and other collaboratorsActive, not recruitingMultiple MyelomaUnited States
-
Alliance Foundation Trials, LLC.Celgene; Janssen, LPWithdrawnRelapsed or Refractory Multiple Myeloma
-
BayerTerminatedMultiple MyelomaKorea, Republic of, Spain, United States
-
PfizerCompletedMultiple MyelomaUnited States, Germany, Czech Republic
-
Wuhan Union Hospital, ChinaRecruitingMultiple Myeloma | Extramedullary Multiple Myeloma | Primary Plasma Cell LeukemiaChina
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)CompletedPrimary Systemic Amyloidosis | Light Chain Deposition DiseaseUnited States
-
National Cancer Institute (NCI)Terminated
-
PETHEMA FoundationBristol-Myers Squibb; Sanofi; Adknoma; Start from scratchNot yet recruitingNewly Diagnosed Multiple MyelomaSpain
-
Guangdong Provincial People's HospitalRecruitingImmunoglobulin Light-Chain AmyloidosisChina
-
GlaxoSmithKlineIqvia Pty LtdCompletedMultiple MyelomaUnited States, Australia, Spain, United Kingdom, Canada
-
Novartis PharmaceuticalsCompletedMultiple MyelomaChina, United States, Italy, Taiwan, Egypt, Japan, Turkey, Germany, Netherlands, Canada, Australia, Austria, Israel, Sweden, United Kingdom, Korea, Republic of, Spain, Hong Kong, Thailand, France, Belgium, Norway, South Africa, Brazil, ... and more
-
Janssen Research & Development, LLCRecruitingRelapsed or Refractory Multiple MyelomaUnited States, Canada, Australia, China, Germany, Belgium, Malaysia, Turkey, Israel, Sweden, Spain, United Kingdom, Czechia, Denmark, Brazil, Italy, France, Japan, Netherlands, Poland, Austria, Portugal, Greece, India
-
University of Michigan Rogel Cancer CenterJanssen Scientific Affairs, LLCActive, not recruiting
-
University of Michigan Rogel Cancer CenterCompletedMultiple MyelomaUnited States, Canada
-
SCRI Development Innovations, LLCMillennium Pharmaceuticals, Inc.; CephalonCompleted
-
Bristol-Myers SquibbTerminatedMultiple MyelomaUnited States, Italy, France, Spain
-
Bristol-Myers SquibbExelixisCompletedAdvanced Cancer, Various, NOSUnited States
-
Stichting European Myeloma NetworkJanssen PharmaceuticaRecruitingMultiple MyelomaAustria, Greece, Italy, Netherlands, Germany
-
The First Affiliated Hospital with Nanjing Medical...Recruiting
-
GlaxoSmithKlineRecruitingMultiple MyelomaChina, Korea, Republic of, Australia, Italy, Spain, United States, Brazil, Czechia, France, Germany, Greece, Israel, Japan, New Zealand, Poland, Russian Federation, Turkey, United Kingdom
-
University of Heidelberg Medical CenterActive, not recruiting
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)TerminatedStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Multiple MyelomaUnited States
-
RenJi HospitalThe First Affiliated Hospital with Nanjing Medical University; The First Affiliated... and other collaboratorsRecruiting
-
Janssen Research & Development, LLCCompletedMultiple MyelomaKorea, Republic of, Malaysia, China, Taiwan, Hong Kong
-
GlaxoSmithKlineActive, not recruiting
-
University of Heidelberg Medical CenterCompleted
-
Nantes University HospitalJanssen PharmaceuticaNot yet recruiting
-
AbbVieRecruiting
-
Memorial Sloan Kettering Cancer CenterJanssen PharmaceuticalsRecruitingMultiple Myeloma | Monoclonal Gammopathy of Renal SignificanceUnited States
-
Janssen Research & Development, LLCPharmacyclics LLC.Active, not recruitingLymphoma, Mantle-CellTaiwan, Thailand, Malaysia, India, Puerto Rico, Spain, Turkey, Czechia, Brazil, Greece, Poland, Sweden, Romania
-
Janssen Research & Development, LLCActive, not recruitingMultiple MyelomaUnited States, Belgium, Germany, Netherlands, Israel, Spain, Saudi Arabia, France
-
Janssen Research & Development, LLCActive, not recruitingMultiple MyelomaCanada, United States, Belgium, Korea, Republic of, United Kingdom, Sweden, Italy, Denmark, Japan, Taiwan, China, Germany, Spain, France, Netherlands, Turkey, Russian Federation, Poland, Greece, Argentina, Brazil
-
Janssen Research & Development, LLCActive, not recruitingMultiple MyelomaUnited States, Netherlands, Belgium, Korea, Republic of, United Kingdom, Sweden, Denmark, Italy, Japan, Germany, France, Spain, Australia, Israel, Poland, Greece
-
University Health Network, TorontoAstellas Pharma Inc; Multiple Myeloma Research ConsortiumTerminatedMultiple MyelomaUnited States, Canada
-
Dana-Farber Cancer InstituteCompletedLymphoma | Leukemia | Myelodysplastic SyndromeUnited States
-
University of MiamiWithdrawnMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
University Hospital of CreteCompletedNon Small Cell Lung Cancer | MetastaticGreece
-
M.D. Anderson Cancer CenterMillennium Pharmaceuticals, Inc.CompletedLymphoma | Mantle Cell LymphomaUnited States